Ilona J.M. den Hartog

Newly-derived neuroblastoma cell lines propagated in serum-free media recapitulate the genotype and phenotype of primary neuroblastoma tumours

Laurel T. Bate-Eya, Marli E. Ebus, Jan Köster et al. · European Journal of Cancer · 2013 · 67 citations

Tumor Biology, Primary Neuroblastoma Tumours, Tumor Innervation +7

Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma

M. Emmy M. Dolman, Evon Poon, Marli E. Ebus et al. · Clinical Cancer Research · 2015 · 67 citations

High efficacy of the BCL-2 inhibitor ABT199 (venetoclax) in BCL-2 high-expressing neuroblastoma cell lines and xenografts and rational for combination with MCL-1 inhibition

Laurel T. Bate-Eya, Ilona J.M. den Hartog, Ida van der Ploeg et al. · Oncotarget · 2016 · 60 citations · Full text

Targeted BCL2 inhibition effectively inhibits neuroblastoma tumour growth

Fieke Lamers, Linda Schild, Ilona J.M. den Hartog et al. · European Journal of Cancer · 2012 · 54 citations · Full text

Anti-cancer Agent, Tumor Suppressor, Medicine +4

Liquid chromatography–tandem mass spectrometric assay for the cyclin-dependent kinase inhibitor AT7519 in mouse plasma

M. Emmy M. Dolman, Ilona J.M. den Hartog, Jan J. Molenaar et al. · Journal of Pharmaceutical and Biomedical Analysis · 2013 · 11 citations

Biochemistry, Medicine, Natural Sciences +8